Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia

NCT02589340 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Low enrollment

Conditions

Parkinson's Disease
Dyskinesias
Movement Disorders

Interventions

DRUG: Buspirone
DRUG: Placebo

Sponsor

Oregon Health and Science University

Collaborators

[object Object]